Welcome to San Francisco Biotech Networks DAILY for 01/11/2026. Daily news and jobs are listed below. Please forward this email to your colleagues so they can subscribe at biotechnetworks.org/daily

​​​​​​​

Click a link below to view the mailing archive as if it had been sent to you.

2020-02-29 01:30How Vineti Inc. CEO Amy Ross employs laser focus on patient therapies and more...
2020-02-28 01:30Denali Therapeutics Reports Full Year 2019 Financial Results and Business Highlights and more...
2020-02-27 01:30Coherus BioSciences Management to Present at the 40th Annual Cowen Healthcare Conference and more...
2020-02-26 01:30Menlo Therapeutics to Host Conference Call Tomorrow to Discuss Results from Phase 2 Trial of Serlopitant in Patients with Chronic Pruritus of Unknown Origin and more...
2020-02-25 01:30Atreca to Present at the Cowen and Company 40th Annual Health Care Conference and more...
2020-02-24 01:30S2 Genomics Launches the Singulator™ 100 to Automate Tissue Preparation for Single-Cell and Single-Nucleus Analyses
2020-02-22 01:3089bio to Present at the SVB Leerink 9th Annual Global Healthcare Conference and more...
2020-02-21 01:30Startup gobbles up $60M from high-profile investors to target food allergies and more...
2020-02-20 01:30Twist Bioscience Announces Pricing of Upsized $130.0 Million Public Offering of Common Stock and more...
2020-02-19 01:30Kaiser hooks up S.F. General Hospital with $3M to address root cause of addiction and more...
2020-02-16 01:30Adverum Biotechnologies Announces Closing of $150 Million Public Offering of Common Stock and more...
2020-02-15 01:30Algorithms are better than people in predicting recidivism, study says and more...
2020-02-14 01:30CloudCath raises $12M to improve at-home dialysis monitoring and more...
2020-02-13 01:30Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer and more...
2020-02-12 01:30FibroGen Announces U.S. FDA Acceptance of New Drug Application for Roxadustat for the Treatment of Anemia of Chronic Kidney Disease and more...
2020-02-11 01:30Alkahest Announces Initiation of Phase 2b Clinical Trial of AKST4290 in Patients with Treatment-Naïve Wet Age-Related Macular Degeneration and more...
2020-02-08 01:30RAPT Therapeutics Announces Pricing of $75 Million Public Offering and more...
2020-02-07 01:30Aduro Biotech Announces Milestone Achieved under Merck Collaboration for Initiation of Phase 2 Trial of Anti-CD27 Agonist MK-5890 in Non-Small Cell Lung Cancer and more...
2020-02-06 01:30Menlo Therapeutics Announces Publication of Phase 2 Results for Serlopitant for the Treatment of Pruritus Associated with Psoriasis in the Journal of the American Academy of Dermatology and more...
2020-02-05 01:3010x Genomics to Report Fourth Quarter and Full Year 2019 Financial Results on February 18, 2020 and more...
2020-02-04 01:30CytomX Therapeutics Appoints Alison L. Hannah, M.D. as Chief Medical Officer and more...
2020-02-02 01:30Denali Therapeutics Announces Closing of Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
2020-02-02 01:00Denali Therapeutics Announces Closing of Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
2020-02-01 01:30Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy and more...

 

<< Archive Index • Subscribe >>

 

© Biotech Networks. You're receiving this email because you've signed up to receive updates from us.

If you'd prefer not to receive updates, you can unsubscribe.
 
© FeedBlitz® - Win the Inbox ™ | feedblitz.com | info@feedblitz.com | Privacy | Terms of Service
 English | Português | Français | Español | Italiano | Nederlands | Svenska | Deutsch | 日本語